Skip to main navigation
Lycia Therapeutics Inc. corporate website
  • About
    • Overview
    • Team
    • Partnering
  • Technology
    • Lytac Platform
    • Publications
  • Pipeline
    • Programs
    • Disease Area Focus
  • Careers
    • Culture
    • Benefits
    • Job Openings
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock
      • Stock Quote & Chart
    • Governance
      • Documents & Charters
      • Board of Directors
      • Management Team
      • Committee Composition
    • Financials
      • SEC Filings
    • Shareholder Services
      • Investor FAQs
      • Email Alerts
      • Contact Us
  • Contact
Investors

SEC Filing Details

Document Details

Form
S-1MEF
Filing Date
Oct 22, 2026
Document Date
Oct 22, 2026
Form Description
Registration of up to an additional 20% of securities for any offering registered on an S-1
Filing Group
Registration Statements
Company
Lycia Therapeutics Inc.
Issuer
LYCIA THERAPEUTICS, INC.

Filing Formats

iXBRL
View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
XML - XBRL INSTANCE DOCUMENT
Lycia Therapeutics Inc. corporate website

400 East Jamie Court, Suite 200 
South San Francisco, CA 94080

info@lyciatx.com
  • About
  • Technology
  • Pipeline
  • News
  • Careers
  • Investors
  • Contact
© 2026 Lycia Therapeutics Inc.
  • | Privacy Policy
  • | Terms of Use
  • | Consumer Health Data Privacy Notice
Lycia Therapeutics Inc. corporate website
  • About
    • Overview
    • Team
    • Partnering
  • Technology
    • Lytac Platform
    • Publications
  • Pipeline
    • Programs
    • Disease Area Focus
  • Careers
    • Culture
    • Benefits
    • Job Openings
  • Investors
    • Overview
    • News & Events
      • Press Releases
      • Events & Presentations
    • Stock
      • Stock Quote & Chart
    • Governance
      • Documents & Charters
      • Board of Directors
      • Management Team
      • Committee Composition
    • Financials
      • SEC Filings
    • Shareholder Services
      • Investor FAQs
      • Email Alerts
      • Contact Us
  • Contact